People: Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

38.93USD
17 Apr 2014
Price Change (% chg)

$0.55 (+1.43%)
Prev Close
$38.38
Open
$38.26
Day's High
$39.00
Day's Low
$38.14
Volume
2,531,048
Avg. Vol
2,326,954
52-wk High
$40.37
52-wk Low
$32.70

Search Stocks

Capek, John 

Brief Biography

Dr. John M. Capek, Ph.D., is Executive Vice President - Medical Devices of Abbott Laboratories since July 2007. He is responsible for Abbott's Vascular, Diabetes Care, Ophthalmology and Animal Health businesses. Previously, he served as Senior Vice President, Abbott Vascular, heading up Abbott's global vascular business. Dr. Capek served in various management roles at Guidant, including president, Guidant Vascular Intervention and Vice President and General Manager of Bioabsorbable Vascular Solutions. He also served as Vice President and General Manager of Guidant Germany and Vice President, Marketing, Guidant Cardiac Rhythm Management Group. Before joining Guidant, Dr. Capek was manager of New Product Technology at Eli Lilly & Company. Dr. Capek has a Bachelor's degree in Biomedical Engineering, a Master's degree in Biomedical Engineering, a Master's degree in Electrical Engineering, a Ph.D. in Biomedical Engineering and a Master's degree in Business Administration from Rensselaer Polytechnic Institute.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
1,357,580 -- 2,253,860 5,341,410

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Miles White

25,118,800

Thomas Freyman

9,663,780

Hubert Allen

--

Richard Ashley

--

Brian Blaser

--

John Capek

5,341,410
As Of 30 Dec 2012
Search Stocks